AzTrials
AzTrials

Postoperative Pain, AcutePhase 4NCT05386121

Erector Spinae Plane Block Versus Quadratus Lumborum Block for Open Renal Surgeries in Children

A Phase 4 study testing Ultrasound-guided Erector Spinae Plane Block, Ultrasound-guided Quadratus Lumborum Block and Ultrasound Machine in people with Postoperative Pain, Acute, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Open renal surgeries are associated with significant postoperative pain; early control of the perioperative pain is associated with decrease of hemodynamic variations during the surgery, early mobilization, better quality of functional recovery \& early discharge of patients. Read more about this study

Who is it for?
Ages 1 year to 6 years
Conditions the study is for
Postoperative Pain, Acute
What is being tested?
Ultrasound-guided Erector Spinae Plane Block, Ultrasound-guided Quadratus Lumborum Block and Ultrasound Machine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
20 May 2022to 15 Sep 2022
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 6 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • American society of anesthesiologists (ASA) class I and II
  • Children undergoing unilateral open renal surgeries

Who cannot join

  • Parents refusal for the block
  • Bleeding disorders (platelets count < 100,000/uL; INR > 1.5; PC < 60%)
  • Skin lesion, wounds or infection at the puncture site.
  • Known allergy to local anesthetic drugs

Trial locations and contacts

No sites are listed yet.

Kareem MA Nawwar, M.D. contact

+201003878369

drknawwar@cu.edu.eg

About this study

Official title: Ultrasound Guided Erector Spinae Plane Block Versus Quadratus Lumborum Block in Pediatric Open Renal Surgeries: A Randomized Comparative Study.

Open renal surgeries are associated with significant postoperative pain; early control of the perioperative pain is associated with decrease of hemodynamic variations during the surgery, early mobilization, better quality of functional recovery \& early discharge of patients. Side effects of systemic opioids, as well as difficulty to monitor their response, are major limitations to their use.

Pediatric regional anesthesia (PRA) is one of the most valuable and safe tools to treat perioperative pain, and is an essential part of modern anesthetic practice. Neuraxial analgesia for pediatric patients is a mode of pain control that gained popularity in the last few decades as it decreases opioid exposure, shortens recovery room time \& hospital stay. Caudal block is the most commonly used neuraxial anesthesia in pediatric patients. However, its major side effect is urinary retention and excessive motor block.

Read more

Considerable progress has been made in the practice of PRA over the past few years including incorporation of ultrasound guidance, with promising novel regional anesthesia techniques, especially the anterolateral and the posterolateral trunk blocks.

In this study, the investigators will compare the ultrasound guided quadratus lumborum block (QLB) with erector spinae plane block (ESPB), regarding the duration and quality of postoperative analgesia in pediatric patients undergoing unilateral open renal surgeries under general anesthesia. The study hypothesis is that QLB can provide a more superior postoperative pain relief to ESPB in children undergoing open renal surgeries.

Being tested
Ultrasound-guided Erector Spinae Plane Block, Ultrasound-guided Quadratus Lumborum Block, Ultrasound Machine, Echogenic needle, Fentanyl
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound-guided Erector Spinae Plane BlockProcedure or surgery

    Using a 22-gauge 80 mm echogenic needle under ultrasound guidance, 0.5 mL/kg of bupivacaine 0.125% will be injected in the fascial plane deep to erector spinae muscle after confirming correct needle location by a negative aspiration test then by injecting 0.5-1 ml saline and observing the fluid lifting the erector spinae muscle off the transverse process (hydrodissection). The ultrasound probe will be placed 2-3 cm lateral to the spinous process on a parasagittal plane, to visualize the erector spinae muscle and transverse process, directing the needle craniocaudally using the in-plane technique. The spread of the injectate will be observed to distribute within this plane.

  • Ultrasound-guided Quadratus Lumborum BlockProcedure or surgery

    Using a 22-gauge 80 mm echogenic needle under ultrasound guidance, 0.5 mL/kg of bupivacaine 0.125% will be injected in the fascial plane between the quadratus lumborum and psoas major muscle after confirming correct needle location by a negative aspiration test then by injecting 0.5-1 ml saline (hydrodissection). The ultrasound probe will be placed 2-3 cm lateral to the L2 spinous process on an axial plane, to visualize the transverse process with psoas major muscle anterior, quadratus lumborum muscle lateral and erector spinae muscle posterior to it. The needle is inserted from the medial side of the probe and advanced laterally using the in-plane technique. The spread of the injectate will be observed to distribute within the target plane.

  • Ultrasound MachineDevice

    Sonosite S-Nerve (USA) with a linear multi-frequency 6-13 MHz (hockey stick) transducer

  • Echogenic needleDevice

    A 22-gauge 80 mm needle the sonoplex needle manufactured by PAJUNK (USA)

  • FentanylDrug

    Given intravenously (1 µg/kg) as part of induction of general anesthesia (GA) added to propofol 2 mg/kg and atracurium 0.5 mg/kg Intraoperatively, intravenous fentanyl 0.5 µg/kg (with a maximum dose of 2 µg/kg) will be administered in response to any increase in hemodynamics by more than 20% of baseline values in response to skin incision or there after throughout surgery (after exclusion of other causes of hemodynamic changes)

  • PethidineDrug

    Will be given intravenously as a rescue analgesic (0.5 mg/kg with maximal dose 1.5 mg/kg) in both study groups if Children's Hospital Eastern Ontario Pain Scale (CHEOPS) more than 6. Quality of postoperative analgesia will be assessed using CHEOPS pain score at time transfer to PACU, 15, 30 minutes then 1, 2, 4, 6 hours postoperatively.

Study groups in NCT05386121
Study groupRoleWhat they receive
Erector spinae plane block (ESPB) groupActive comparator30 child will receive a preoperative unilateral single shot US-guided erector spinae plane block at the level of T9 vertebra in the lateral position after induction of general anesthesia, using 0.5 mL/kg of bupivacaine 0.125%
Receives: Procedure: Ultrasound-guided Erector Spinae Plane Block; Device: Ultrasound Machine; Device: Echogenic needle; Drug: Fentanyl; Drug: Pethidine
Quadratus lumborum block (QLB) groupActive comparator30 child will receive a preoperative unilateral single shot US-guided quadratus lumborum block at the level of L2 spinous process in the lateral position after induction of general anesthesia, using 0.5 mL/kg of bupivacaine 0.125%
Receives: Procedure: Ultrasound-guided Quadratus Lumborum Block; Device: Ultrasound Machine; Device: Echogenic needle; Drug: Fentanyl; Drug: Pethidine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to first postoperative rescue analgesia

    Time in minutes when postoperative Children's Hospital Eastern Ontario Pain Scale (CHEOPS) pain score exceeds 6 for the first time. Children's Hospital Eastern Ontario Pain Scale is a pain score with the least possible score is 4, while the highest possible score 13 (worse outcome).

    Measured: 12 hours

Secondary outcomes (5)
  1. Total opioid analgesic consumption in the first 12 hours postoperative period

    when postoperative Children's Hospital Eastern Ontario Pain Scale (CHEOPS) pain score ˃ 6 in the first 12 hours postoperatively. Children's Hospital Eastern Ontario Pain Scale is a pain score with the least possible score is 4, while the highest possible score 13 (worse outcome).

    Measured: from time of patient transfer to the PACU, till 12 hours postoperatively

  2. Intraoperative mean arterial blood pressure

    measured from induction of general anesthesia, after performance of the nerve block and at 1,5,10, 15 mins. after

    Measured: During surgery (from induction of general anesthesia till 15 mins. after performance of the nerve block)

  3. Intraoperative heart rate

    measured before and after induction of general anesthesia, after performance of the nerve block and at 1,5,10, 15 mins. after

    Measured: During surgery (from induction of general anesthesia till 15 mins. after performance of the nerve block)

  4. Postoperative pain score

    measured at time of patient transfer to the PACU, 15, 30 mins, 1 ,2 , 4 ,6 ,12 hours after surgery

    Measured: from time of patient transfer to the PACU, till 12 hours postoperatively

  5. Block performance time

    Time to perform ultrasound guided nerve block

    Measured: Time from ultrasound visualization of target injection site to end of local anesthetic (bupivacaine) deposition up to 15 mins.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 May 2022
  2. Study start20 May 2022 (estimated)
  3. Primary completion1 Sep 2022 (estimated)
  4. Study completion15 Sep 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05386121
Sponsor's protocol ID
md-13-2022
Status last verified
May 2022
First submitted
8 May 2022
Last updated
23 May 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Ultrasound-guided Erector Spinae Plane Block, Ultrasound-guided Quadratus Lumborum Block and Ultrasound Machine in people with Postoperative Pain, Acute, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 May 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Kareem MA Nawwar, M.D. (+201003878369, drknawwar@cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to first postoperative rescue analgesia (time frame: 12 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in